🔎 Trials Near Me

Akèy › Osteyosakòm › Kalifòni › Mountain View

Etid klinik pou Osteyosakòm nan Mountain View, CA

8 etid pou Osteyosakòm ap chèche patisipan nan sit nan ak bò kote Mountain View (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Ap rekriteFaz 2
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi lwen
Laj 12 a 39 · Tout sèks · Mizajou Sep 29, 2026 · NCT04616560

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Ap rekriteFaz 3
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi lwen
Jiska laj 50 · Tout sèks · Mizajou Aug 25, 2026 · NCT05235165

SPEARHEAD-3 Pediatric Study

Ap rekriteFaz 1/2
  • Stanford University, Palo Alto · 5 mi lwen
Laj 2 a 21 · Tout sèks · Mizajou Aug 11, 2026 · NCT05642455

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Ap rekriteFaz 1/2
  • Lucille Packard Children's Hospital Stanford, Palo Alto · 5 mi lwen
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Ap rekriteEtid obsèvasyon
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi lwen
Tout laj · Tout sèks · Mizajou May 18, 2026 · NCT01790152

Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors

Ap rekriteFaz 1
  • Stanford University, Palo Alto · 5 mi lwen
Laj 2 a 30 · Tout sèks · Mizajou May 7, 2026 · NCT06500819

Pediatric PET/MR Image Registry

Ap rekriteEtid obsèvasyon
  • Stanford University, School of Medicine, Palo Alto · 5 mi lwen
Jiska laj 40 · Tout sèks · Mizajou Feb 9, 2026 · NCT03458520

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

Ap rekriteFaz 1
  • Stanford University, Stanford · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Feb 8, 2024 · NCT04282044

Etid Osteyosakòm nan lòt vil

Lòt etid nan Mountain View

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.